| Symbol: |
C17orf104
|
| Description: |
chromosome 17 open reading frame 104 [Source:HGNC Symbol;Acc:26670]
|
| Location: |
Chr17:42733762-42767676[+]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:219
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| C17orf104 |
N-(6'-Chrysenyl)-4-(1'-piperidinyl)-D-2,3-dioxalono-butane-1 ,4-dicarboximide |
0.046 |
Up |
| C17orf104 |
NSC 721536 |
0.024 |
Up |
| C17orf104 |
NSC 721875 |
0.012 |
Up |
| C17orf104 |
NSC 721877 |
0.018 |
Up |
| C17orf104 |
NSC 722388 |
0.041 |
Up |
| C17orf104 |
NSC 722398 |
0.048 |
Up |
| C17orf104 |
4-[4-(2-Diethylamino-ethylamino)-naphthalen-1-ylazo]-benzene sulfonamide |
0.01 |
Up |
| C17orf104 |
NSC 723378 |
0.03 |
Up |
| C17orf104 |
NSC 723548 |
0.014 |
Up |
| C17orf104 |
S-(dimethylarsino)-3-mercapto-1,2-propyl dibenzoate |
0.031 |
Up |
| C17orf104 |
NSC 724771 |
0.001 |
Up |
| C17orf104 |
(1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]he xadec-9-ene |
0.045 |
Up |
| C17orf104 |
ARTEMISININ DIMER HEMISUCCINATE |
0.025 |
Up |
| C17orf104 |
Bis-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline) -6-propylamino}ethane Bis(trifluoroacetate |
0.027 |
Up |
| C17orf104 |
1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one |
0.012 |
Up |
Expression pattern: Sensitivity / Resistance
Total:15 Current:13
First Prev Next Last
|
| SNP:
~ Export ~
|
Records:19
Total:2 Current:1
[First] [Prev] Next Last
|
| miRNA:
~ Export ~
|
Records:null
| Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|